Thrombosis, fracture, and percutaneous removal of a patent foramen ovale closure device 1 month after successful deployment.
Several different devices have been developed for the percutaneous closure of interatrial defects and patent foramen ovale. Although the implantation of these devices is both safe and effective, a number of complications, both in the early and the late follow-up, may occur. We describe a case of device fracture manifested early (1 month after implantation) with the formation of massive thrombosis on the right atrial disc. The patient was treated with anticoagulants and the device was percutaneously retrieved. Our images allowed early noninvasive therapy and emphasize the need for echocardiographic follow-up early after implantation.
Gori
Tommaso
T
II Medizinische Klinik für Kardiologie/Angiologie, Johannes Gutenberg University, Mainz, Germany.
Schräder
Rainer
R
Genth-Zotz
Sabine
S
D000925:Anticoagulants / Q000627:therapeutic use; D006328:Cardiac Catheterization / Q000009:adverse effects* / Q000295:instrumentation*; D020878:Device Removal; D017548:Echocardiography, Transesophageal; D005260:Female; D054092:Foramen Ovale, Patent / Q000000981:diagnostic imaging / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D011474:Prosthesis Design; D011475:Prosthesis Failure; D011859:Radiography; D055989:Septal Occluder Device; D013927:Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy; D013997:Time Factors; D016896:Treatment Outcome
D000925:Anticoagulants